JNJ-95566692 / J&J - LARVOL DELTA

A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies (clinicaltrials.gov) - P1 | N=80 | Not yet recruiting | Sponsor: Janssen Research & Development, LLC

First-in-human • New P1 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology